The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Determination of quality of care for patients with hepatocellular carcinoma in Nova Scotia.
 
Cathie Ouellet
Employment - Eisai; Eisai; Eisai; Eisai
 
Ravi Ramjeesingh
Honoraria - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Roche; Roche; Roche; Roche; Shire; Shire; Shire; Shire
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire
Research Funding - Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst)
Travel, Accommodations, Expenses - Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc